These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24239027)

  • 21. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
    Han WK; Alinani A; Wu CL; Michaelson D; Loda M; McGovern FJ; Thadhani R; Bonventre JV
    J Am Soc Nephrol; 2005 Apr; 16(4):1126-34. PubMed ID: 15744000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma.
    Morrissey JJ; London AN; Lambert MC; Kharasch ED
    Am J Nephrol; 2011; 34(5):391-8. PubMed ID: 21912102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.
    Hu R; Gupta R; Wang Z; Wang C; Sun H; Singamaneni S; Kharasch ED; Morrissey JJ
    Kidney Int; 2019 Dec; 96(6):1417-1421. PubMed ID: 31668633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor size, stage and grade alterations of urinary peptidome in RCC.
    Chinello C; Cazzaniga M; De Sio G; Smith AJ; Grasso A; Rocco B; Signorini S; Grasso M; Bosari S; Zoppis I; Mauri G; Magni F
    J Transl Med; 2015 Oct; 13():332. PubMed ID: 26482227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcript levels of aquaporin 1 and carbonic anhydrase IV as predictive indicators for prognosis of renal cell carcinoma patients after nephrectomy.
    Takenawa J; Kaneko Y; Kishishita M; Higashitsuji H; Nishiyama H; Terachi T; Arai Y; Yoshida O; Fukumoto M; Fujita J
    Int J Cancer; 1998 Feb; 79(1):1-7. PubMed ID: 9495349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of utility of tumor size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma.
    Maruyama M; Yoshizako T; Uchida K; Araki H; Tamaki Y; Ishikawa N; Shiina H; Kitagaki H
    Acta Radiol; 2015 Feb; 56(2):250-6. PubMed ID: 24518687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
    Kaya K; Ayan S; Gokce G; Kilicarslan H; Yildiz E; Gultekin EY
    Scand J Urol Nephrol; 2005; 39(1):25-9. PubMed ID: 15764267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma.
    Kaneko S; Matsumoto K; Minamida S; Hirayama T; Fujita T; Kodera Y; Iwamura M
    Asian Pac J Cancer Prev; 2016; 17(3):1399-404. PubMed ID: 27039779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of urinary vascular endothelial growth factor and microvessel density in patients with renal cell carcinoma.
    Chang SG; Jeon SH; Lee SJ; Choi JM; Kim YW
    Urology; 2001 Dec; 58(6):904-8. PubMed ID: 11744455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F
    Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma.
    Zhang PL; Mashni JW; Sabbisetti VS; Schworer CM; Wilson GD; Wolforth SC; Kernen KM; Seifman BD; Amin MB; Geddes TJ; Lin F; Bonventre JV; Hafron JM
    Int Urol Nephrol; 2014 Feb; 46(2):379-88. PubMed ID: 23979814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of radiologic tumor volume and pathologic tumor volume in renal cell carcinoma (RCC).
    Choi SM; Choi DK; Kim TH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    PLoS One; 2015; 10(3):e0122019. PubMed ID: 25799553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of increased preoperative serum high sensitive C-reactive protein and procalcitonin levels on grade and stage of clear cell renal cell carcinoma.
    Hamidi N; Gökçe MI; Süer E; Baltaci S
    Clin Nephrol; 2015 Apr; 83(4):225-30. PubMed ID: 25707457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.